1. Home
  2. NEPH vs LTRN Comparison

NEPH vs LTRN Comparison

Compare NEPH & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$4.93

Market Cap

60.0M

Sector

Health Care

ML Signal

HOLD

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$3.48

Market Cap

49.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEPH
LTRN
Founded
1997
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.0M
49.9M
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
NEPH
LTRN
Price
$4.93
$3.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$25.00
AVG Volume (30 Days)
64.7K
62.3K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$17,930,000.00
N/A
Revenue This Year
$33.32
N/A
Revenue Next Year
$12.27
N/A
P/E Ratio
$37.67
N/A
Revenue Growth
32.36
N/A
52 Week Low
$1.39
$2.55
52 Week High
$6.42
$6.12

Technical Indicators

Market Signals
Indicator
NEPH
LTRN
Relative Strength Index (RSI) 48.86 47.50
Support Level $4.65 $3.19
Resistance Level $5.34 $3.72
Average True Range (ATR) 0.39 0.27
MACD -0.02 -0.00
Stochastic Oscillator 40.46 32.72

Price Performance

Historical Comparison
NEPH
LTRN

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

Share on Social Networks: